Development of the Metabolic Syndrome: Study Design and Baseline Data of the Lufthansa Prevention Study (LUPS), A Prospective Observational Cohort Survey.

Adult Blood Glucose / metabolism Cross-Sectional Studies Depression / diagnosis Dyslipidemias / diagnosis Early Diagnosis Female Germany / epidemiology Health Surveys Humans Insulin Resistance Life Style Male Metabolic Syndrome / diagnosis Middle Aged Obesity, Abdominal / diagnosis Prospective Studies Research Design Risk Factors

Journal

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
ISSN: 1439-3646
Titre abrégé: Exp Clin Endocrinol Diabetes
Pays: Germany
ID NLM: 9505926

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 27 11 2018
medline: 9 9 2021
entrez: 27 11 2018
Statut: ppublish

Résumé

The

Identifiants

DOI: 10.1055/a-0767-6361 PMID: 30477037
pubmed: 30477037
doi: 10.1055/a-0767-6361
doi:

Substances chimiques

Blood Glucose 0

Banques de données

ClinicalTrials.gov
['NCT01313156']

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

777-787

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

No conflict of interest has been declared by the authors.

Auteurs

Dirk Müller-Wieland (D)

Department of Medicine I, University Hospital Aachen, Aachen, Germany.

Christiane Altenburg (C)

Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Heiko Becher (H)

Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Janine Burchard (J)

Asklepios Medical School Campus Hamburg, Semmelweis University, Hamburg, Germany.

Anett Frisch (A)

Asklepios Medical School Campus Hamburg, Semmelweis University, Hamburg, Germany.

Jan Gebhard (J)

Aeromedical Center Lufthansa, Hamburg, Germany.

Jutta Haas (J)

Asklepios Medical School Campus Hamburg, Semmelweis University, Hamburg, Germany.

Volker Harth (V)

Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Jörg Heeren (J)

Department of Biochjemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Johannes Hengelbrock (J)

Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Maximilian von Karais (M)

Aeromedical Center Lufthansa, Hamburg, Germany.

Birgit Knebel (B)

Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center at the Heinrich-Heine-University Düsseldorf, Leibniz Center for Diabetes Research, Düsseldorf, Germany.

Jörg Kotzka (J)

Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center at the Heinrich-Heine-University Düsseldorf, Leibniz Center for Diabetes Research, Düsseldorf, Germany.

Bernd Löwe (B)

Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Nikolaus Marx (N)

Department of Medicine I, University Hospital Aachen, Aachen, Germany.

Hans Pinnschmidt (H)

Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Alexandra Preisser (A)

Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Matthias Rose (M)

Department of Psychosomatic Medicine, Charite University Medical Center, Berlin, Germany.

Barbara Sawitzky-Rose (B)

Diabetes Center Berlin Rose, Berlin, Germany.

Ludger Scheja (L)

Department of Biochjemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Claudia Terschüren (C)

Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Monika Töller (M)

Department of Endocrinology, Diabetology and Rheeumatology, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.

Eik Vettorazzi (E)

Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Karl Wegscheider (K)

Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Development of the Metabolic Syndrome: Study...
questionsmedicales.fr › Glucides › Sucres › Oses › Hexose › Glucose › Glycémie › Development of the Metabolic Syndrome: Study...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études transversales › Development of the Metabolic Syndrome: Study...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Émotions › Dépression › Development of the Metabolic Syndrome: Study...
questionsmedicales.fr › Maladies métaboliques et nutritionnelles › Maladies métaboliques › Troubles du métabolisme lipidique › Dyslipidémies › Development of the Metabolic Syndrome: Study...
questionsmedicales.fr › Diagnostic › Diagnostic précoce › Development of the Metabolic Syndrome: Study...
questionsmedicales.fr › Régions géographiques › Europe › Allemagne › Development of the Metabolic Syndrome: Study...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Enquêtes de santé › Development of the Metabolic Syndrome: Study...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Development of the Metabolic Syndrome: Study...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Insulinorésistance › Development of the Metabolic Syndrome: Study...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Mode de vie › Development of the Metabolic Syndrome: Study...
questionsmedicales.fr › Maladies métaboliques et nutritionnelles › Maladies métaboliques › Syndrome métabolique X › Development of the Metabolic Syndrome: Study...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Development of the Metabolic Syndrome: Study...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Obésité › Obésité abdominale › Development of the Metabolic Syndrome: Study...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Development of the Metabolic Syndrome: Study...
questionsmedicales.fr › Disciplines des sciences naturelles › Science › Recherche › Plan de recherche › Development of the Metabolic Syndrome: Study...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Development of the Metabolic Syndrome: Study...